Witold B. Rybka

2.9k total citations
79 papers, 1.7k citations indexed

About

Witold B. Rybka is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Witold B. Rybka has authored 79 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Hematology, 23 papers in Oncology and 18 papers in Immunology. Recurrent topics in Witold B. Rybka's work include Hematopoietic Stem Cell Transplantation (37 papers), Acute Myeloid Leukemia Research (14 papers) and Immune Cell Function and Interaction (12 papers). Witold B. Rybka is often cited by papers focused on Hematopoietic Stem Cell Transplantation (37 papers), Acute Myeloid Leukemia Research (14 papers) and Immune Cell Function and Interaction (12 papers). Witold B. Rybka collaborates with scholars based in United States, Canada and China. Witold B. Rybka's co-authors include David F. Claxton, W. Christopher Ehmann, Hong Zheng, Todd D. Schell, Hui Zeng, Liuluan Zhu, Yaxian Kong, Edward D. Ball, Massimo Trucco and Paulo Fontes and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Witold B. Rybka

77 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Witold B. Rybka United States 21 797 676 663 320 254 79 1.7k
Leo Luznik United States 22 910 1.1× 658 1.0× 1.3k 1.9× 55 0.2× 237 0.9× 60 1.8k
Kazuma Ikeda Japan 23 476 0.6× 470 0.7× 446 0.7× 98 0.3× 390 1.5× 106 1.6k
Axel Schulenburg Austria 18 216 0.3× 337 0.5× 511 0.8× 86 0.3× 235 0.9× 41 990
Uta Oelschlägel Germany 22 635 0.8× 488 0.7× 1.2k 1.8× 41 0.1× 428 1.7× 53 1.8k
TC Graham United States 23 367 0.5× 328 0.5× 973 1.5× 118 0.4× 206 0.8× 69 1.5k
Brian C. Betts United States 21 614 0.8× 390 0.6× 578 0.9× 34 0.1× 196 0.8× 68 1.2k
Katrin Moser Germany 14 923 1.2× 171 0.3× 267 0.4× 65 0.2× 363 1.4× 15 1.6k
WJ Miller United States 12 312 0.4× 242 0.4× 1.0k 1.5× 68 0.2× 272 1.1× 19 1.4k
Momoko Nishikori Japan 20 566 0.7× 906 1.3× 117 0.2× 91 0.3× 335 1.3× 99 1.7k
Lene Meldgaard Knudsen Denmark 23 430 0.5× 782 1.2× 1.1k 1.7× 60 0.2× 989 3.9× 50 1.9k

Countries citing papers authored by Witold B. Rybka

Since Specialization
Citations

This map shows the geographic impact of Witold B. Rybka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Witold B. Rybka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Witold B. Rybka more than expected).

Fields of papers citing papers by Witold B. Rybka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Witold B. Rybka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Witold B. Rybka. The network helps show where Witold B. Rybka may publish in the future.

Co-authorship network of co-authors of Witold B. Rybka

This figure shows the co-authorship network connecting the top 25 collaborators of Witold B. Rybka. A scholar is included among the top collaborators of Witold B. Rybka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Witold B. Rybka. Witold B. Rybka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sivik, Jeffrey, Erik Lehman, Kevin Rakszawski, et al.. (2024). The addition of doxycycline to fluoroquinolones for bacterial prophylaxis in autologous stem cell transplantation for multiple myeloma. Transplant Infectious Disease. 26(2). e14241–e14241. 1 indexed citations
2.
Gregory, Gareth P., Shaji Kumar, Ding Wang, et al.. (2021). Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study. Blood Advances. 6(4). 1232–1242. 24 indexed citations
3.
Fisher, Carolyn, Jozef Malysz, Seema Naik, et al.. (2020). Unexpected Short-Tandem-Repeat Patterns in Posttransplant Chimerism Testing: Investigation of 3 Cases with Help from Forensic Science. Laboratory Medicine. 51(6). 635–641. 1 indexed citations
4.
Jia, Bei, Kevin Rakszawski, David F. Claxton, et al.. (2019). Eomes+T-betlow CD8+ T Cells Are Functionally Impaired and Are Associated with Poor Clinical Outcome in Patients with Acute Myeloid Leukemia. Cancer Research. 79(7). 1635–1645. 48 indexed citations
5.
Litzow, Mark R., Martin Carroll, Judith E. Karp, et al.. (2018). A randomized trial of three novel regimens for recurrent acute myeloid leukemia demonstrates the continuing challenge of treating this difficult disease. American Journal of Hematology. 94(1). 111–117. 18 indexed citations
6.
7.
Kong, Yaxian, Liuluan Zhu, Todd D. Schell, et al.. (2016). T-Cell Immunoglobulin and ITIM Domain (TIGIT) Associates with CD8+ T-Cell Exhaustion and Poor Clinical Outcome in AML Patients. Clinical Cancer Research. 22(12). 3057–3066. 230 indexed citations
8.
Drabick, Joseph J., Giampaolo Talamo, Jeffrey G. Supko, et al.. (2013). A phase II pilot efficacy trial of the combination regimen peg asparaginase/peg liposomal doxorubicin/dexamethasone (ODD) in patients with refractory lymphoid malignancies (NCT00837200).. Journal of Clinical Oncology. 31(15_suppl). e19502–e19502. 1 indexed citations
9.
Zhu, Junjia, W. Christopher Ehmann, Elliot Epner, et al.. (2012). G-CSF mobilized vs conventional donor lymphocytes for therapy of relapse or incomplete engraftment after allogeneic hematopoietic transplantation. Bone Marrow Transplantation. 48(3). 357–362. 18 indexed citations
10.
Luger, Selina M., Elisabeth Paietta, Rhett P. Ketterling, et al.. (2012). R115777(tipifarnib) Improves Early Survival when Used As Maintenance Therapy for Elderly or Relapsed/Refractory Patients with Acute Myelogenous Leukemia in Remission. Blood. 120(21). 676–676. 2 indexed citations
11.
Claxton, David F., et al.. (2004). Sirolimus and tacrolimus allow engraftment of haploidentical and other alternative donor stem cells after non-myeloablative conditioning. Biology of Blood and Marrow Transplantation. 10. 38–39. 2 indexed citations
12.
Magalhaes‐Silverman, Margarida, Albert D. Donnenberg, John Lister, et al.. (1999). Factors Influencing Mobilization and Engraftment in Patients with Metastatic Breast Cancer Undergoing PBSC Transplantation. Journal of Hematotherapy. 8(2). 167–172. 2 indexed citations
13.
Neudorf, Steven, Witold B. Rybka, Edward D. Ball, et al.. (1997). The Use of Counterflow Centrifugal Elutriation for the Depletion of T Cells from Unrelated Donor Bone Marrow. Journal of Hematotherapy. 6(4). 351–359. 4 indexed citations
14.
Lister, John, et al.. (1997). Busulfan and cyclophosphamide (BU/CY2) as preparative regimen for patients with lymphoma. Bone Marrow Transplantation. 19(8). 777–781. 23 indexed citations
15.
Magalhaes‐Silverman, Margarida, Witold B. Rybka, Barry C. Lembersky, et al.. (1996). High-Dose Cyclophosphamide, Carboplatin, and Etoposide with Autologous Stem Cell Rescue in Patients with Breast Cancer. American Journal of Clinical Oncology. 19(2). 169–173. 7 indexed citations
16.
Nimgaonkar, M, et al.. (1995). A unique population of cd34+cells in cord blood. Stem Cells. 13(2). 158–166. 21 indexed citations
17.
Rybka, Witold B., et al.. (1995). HEMATOPOIETIC PROGENITOR CELL CONTENT OF VERTEBRAL BODY MARROW USED FOR COMBINED SOLID ORGAN AND BONE MARROW TRANSPLANTATION. Transplantation. 59(6). 871–874. 24 indexed citations
18.
Carroll, P. B., Paulo Fontes, Camillo Ricordi, et al.. (1994). Simultaneous solid organ, bone marrow, and islet allotransplantation in type I diabetic patients.. PubMed. 26(6). 3523–4. 8 indexed citations
19.
Ball, Edward D. & Witold B. Rybka. (1993). Autologous Bone Marrow Transplantation for Adult Acute Leukemia. Hematology/Oncology Clinics of North America. 7(1). 201–231. 7 indexed citations
20.
Rybka, Witold B., et al.. (1980). Viability of human marrow after long-term cryopreservation. Cryobiology. 17(5). 424–428. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leo Luznik Breakdown of academic impact, for papers by Kazuma Ikeda Breakdown of academic impact, for papers by Axel Schulenburg Breakdown of academic impact, for papers by Uta Oelschlägel Breakdown of academic impact, for papers by TC Graham Breakdown of academic impact, for papers by Brian C. Betts Breakdown of academic impact, for papers by Katrin Moser Breakdown of academic impact, for papers by WJ Miller Breakdown of academic impact, for papers by Momoko Nishikori Breakdown of academic impact, for papers by Lene Meldgaard Knudsen
Rankless by CCL
2026